Get started
Author

Pip Patrick

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma
2016 · Peter Johnson, Massimo Federico, et al. · New England Journal of Medicine · 821
PDF
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
2014 · Kirit M Ardeshna, Wendi Qian, et al. · The Lancet Oncology · 396
Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial
2016 · B Patel, A A Kirkwood, et al. · Leukemia · 123
PDF
Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial
2018 · Richard A Anderson, Rachel Remedios, et al. · The Lancet Oncology · 85
PDF
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study
2021 · Anthony V. Moorman, Emilio Barretta, et al. · Leukemia · 68
PDF
Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG–PET data for clinical trials in lymphoma
2010 · S.F. Barrington, J.E. MacKewn, et al. · Annals of Oncology · 65
Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma
2013 · T Illidge, C Chan, et al. · British Journal of Cancer · 44
PDF
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial
2022 · David I Marks, Amy A Kirkwood, et al. · The Lancet Haematology · 41
Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma
2018 · Simon Rule, Gordon Cook, et al. · British Journal of Haematology · 36
PDF
Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials
2021 · Thomas Creasey, Emilio Barretta, et al. · Haematologica · 30
PDF
Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia
2023 · Daniel Leongamornlert, Jesús Gutiérrez-Abril, et al. · Blood Advances · 28
PDF
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial
2022 · David I Marks, Laura Clifton-Hadley, et al. · The Lancet Haematology · 28
PDF
RESPONSE‐ADJUSTED THERAPY FOR ADVANCED HODGKIN LYMPHOMA (RATHL) TRIAL: LONGER FOLLOW UP CONFIRMS EFFICACY OF DE‐ESCALATION AFTER a NEGATIVE INTERIM PET SCAN (CRUK/07/033).
2017 · J. Trotman, A. Fosså, et al. · Hematological Oncology · 28
PDF
First Analysis of the UKALL14 Randomized Trial to Determine Whether the Addition of Nelarabine to Standard Chemotherapy Improves Event Free Survival in Adults with T-Cell Acute Lymphoblastic Leukaemia (CRUK/09/006)
2021 · Clare J Rowntree, Amy A Kirkwood, et al. · Blood · 26
Can Baseline Pet‐ct Features Predict Outcomes in Advanced Hodgkin Lymphoma? a Prospective Evaluation of Uk Patients in the Rathl Trial (cruk/07/033)
2017 · L.C. Pike, A.A. Kirkwood, et al. · Hematological Oncology · 22
PDF
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial
2021 · Rachel J. Mitchell, Amy A. Kirkwood, et al. · Blood Advances · 17
First Analysis of the UKALL14 Phase 3 Randomised Trial to Determine If the Addition of Rituximab to Standard Induction Chemotherapy Improves EFS in Adults with Precursor B-ALL (CRUK/09/006)
2019 · David I Marks, Amy A. Kirkwood, et al. · Blood · 12
P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untreated limited-stage classical Hodgkin lymphoma
2022 · John Radford, Toyin Adedayo, et al. · HemaSphere · 11
Quality of life in advanced‐stage, asymptomatic, non‐bulky follicular lymphoma treated with rituximab shows significant improvement compared with watchful‐waiting
2024 · Maria A. V. Marzolini, Wendi Qian, et al. · British Journal of Haematology · 10
APPLICATION OF a GENE EXPRESSION‐BASED MODEL IN COMBINATION WITH FDG‐PET IMAGING TO PREDICT TREATMENT RESPONSE IN ADVANCED HODGKIN LYMPHOMA IN THE RATHL STUDY (CRUK/07/033)
2017 · C.H. Burton, D. Scott, et al. · Hematological Oncology · 9
PDF
Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study
2019 · Emma Das-Gupta, Kirsty J. Thomson, et al. · Blood Advances · 8
PDF
The ‘Obese Medieval Monk’: A multidisciplinary study of a stereotype
2014 · Pip Patrick · University of Michigan Press eBooks · 8
Prognostic Impact of Chromosomal Abnormalities and Copy Number Alterations Among Adults with B-Cell Precursor Acute Lymphoblastic Leukaemia Treated on UKALL14
2019 · Anthony V. Moorman, Ellie Butler, et al. · Blood · 6
S1621 Clinical Efficacy of a Novel Validated Prognostic Index for Trial Design in Adult Acute Lymphoblastic Leukaemia.
2019 · A. Moorman, A. Kirkwood, et al. · HemaSphere · 6
Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation
2021 · Rachael Hough, Andre Lopes, et al. · Blood Advances · 3
PDF
Works count: 47
Citation count: 1,942
H-index: 16
I10-index: 19
Year
Topic
Type